针对CD47的脂质体化疗可调节CD47的表达,并诱导微卫星的不稳定性,从而增强癌症免疫疗法
Qianqian Liu1, Jieping Liang2, Yuan Gu2
1School of Biomedical Engineering, Guangzhou Medical University, Guangzhou 511436, China; Guangzhou National Laboratory, Guangzhou, Guangdong 510000, China.
概括
一种新的纳米免疫疗法,αL-FOX,将化疗与CD47阻断结合起来,以增强微卫星稳定结直肠癌 (MSS-CRC) 的免疫疗法. 这种方法针对CD47过度表达的瘤,减少复发和毒性.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 纳米医学是一种纳米医学.
背景情况:
- 微卫星稳定结直肠癌 (MSS-CRC) 由于免疫性低和免疫抑制,对免疫疗法反应不佳.
- 标准的FOX化疗 (5-甲和甲) 矛盾地增加了CD47和微卫星不稳定性 (MSI).
研究的目的:
- 开发一种向的纳米免疫疗法 (αL-FOX),利用化疗诱导的变化来改善MSS-CRC治疗.
- 通过将化疗与CD47抗体介导向和阻断相结合,提高免疫疗法的疗效.
主要方法:
- 开发CD47抗体装甲脂质体 (αL-FOX) 封装5-FU和氧化.
- 利用αCD47向对选择性向CD47过度表达细胞的输送.
- 在转移性CRC小鼠模型中评估体内疗效.
主要成果:
- αL-FOX在小鼠中表现出自我准能力和显著的瘤抑制.
- 观察到瘤复发率降低和延长生存时间.
- 治疗以一半标准FOX剂量达到这些效果,系统毒性最小.
结论:
- 通过调节化疗反,αL-FOx为免疫治疗耐药的MSS-CRC提供了一个有希望的策略.
- 这种纳米免疫治疗方法增强了抗瘤免疫力,降低了毒性.
- 有针对性的输送和CD47通路阻塞是克服治疗耐药性的关键.
相关概念视频
01:27Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
02:50Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K